Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000599
Filing Date
2025-01-03
Accepted
2025-01-03 17:38:40
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01032025_100137.html 4  
1 form4-01032025_100137.xml 4 7202
  Complete submission text file 0001415889-25-000599.txt   8678
Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BLVD. BRISBANE CA 94005
Business Address
Nolan Sean P. (Reporting) CIK: 0001569926 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 25508139

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)